Kuban D - Search Results

1

Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Tucker SL, Dong L, Bosch WR, Michalski J, Winter K, Mohan R, Purdy JA, Kuban D, Lee AK, Cheung MR, Thames HD, Cox JD. Tucker SL, et al. Among authors: kuban d. Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1253-60. doi: 10.1016/j.ijrobp.2010.01.069. Epub 2010 Jul 2. Int J Radiat Oncol Biol Phys. 2010. PMID: 20598811 Free PMC article.

2

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis.

Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA, Kuban DA, Hancock SL, Smith CD. Shipley WU, et al. Among authors: kuban da. JAMA. 1999 May 5;281(17):1598-604. doi: 10.1001/jama.281.17.1598. JAMA. 1999. PMID: 10235152

3

Intrafraction prostate motion during IMRT for prostate cancer.

Huang E, Dong L, Chandra A, Kuban DA, Rosen II, Evans A, Pollack A. Huang E, et al. Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):261-8. doi: 10.1016/s0360-3016(02)02738-4. Int J Radiat Oncol Biol Phys. 2002. PMID: 12023128

4

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.

Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, von Eschenbach AC, Kuban DA, Rosen I. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1097-105. doi: 10.1016/s0360-3016(02)02829-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 12128107 Clinical Trial.

5

Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial.

Pollack A, Zagars GK, Antolak JA, Kuban DA, Rosen II. Pollack A, et al. Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):677-85. doi: 10.1016/s0360-3016(02)02977-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12377318 Clinical Trial.

6

Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer.

Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Rosser CJ, et al. J Urol. 2002 Nov;168(5):2001-5. doi: 10.1016/S0022-5347(05)64282-6. J Urol. 2002. PMID: 12394695

7

Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.

Huang EH, Pollack A, Levy L, Starkschall G, Dong L, Rosen I, Kuban DA. Huang EH, et al. Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1314-21. doi: 10.1016/s0360-3016(02)03742-2. Int J Radiat Oncol Biol Phys. 2002. PMID: 12459352

8

Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma.

Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL. Rosser CJ, et al. Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):1-6. doi: 10.1016/s0360-3016(02)04468-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12694817

9

Experience of ultrasound-based daily prostate localization.

Chandra A, Dong L, Huang E, Kuban DA, O'Neill L, Rosen I, Pollack A. Chandra A, et al. Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):436-47. doi: 10.1016/s0360-3016(02)04612-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12738318

10

Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate.

Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Rosser CJ, et al. J Urol. 2003 Jun;169(6):2160-5. doi: 10.1097/01.ju.0000058212.00170.a0. J Urol. 2003. PMID: 12771739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters